The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.

The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent opioid overdoses.”

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people's risk of opioid overdose.

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study that adds to a growing body of evidence suggesting it may help manage addiction.